Trials / Completed
CompletedNCT06135168
A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
A Single-center, Randomized, Open-label, Parallel Study to Compare the Pharmacokinetics of Two Polyethylene Glycol Recombinant Human Growth Hormone With Different Preparations by Single Subcutaneous Injection in Chinese Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations after a single administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG-rhGH with new preparation | A single subcutaneous injection of PEG-rhGH with new preparation |
| DRUG | PEG-rhGH with present preparation | A single subcutaneous injection of PEG-rhGH with present preparation |
Timeline
- Start date
- 2023-10-31
- Primary completion
- 2023-11-29
- Completion
- 2024-03-18
- First posted
- 2023-11-18
- Last updated
- 2025-04-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06135168. Inclusion in this directory is not an endorsement.